Completed OBSERVATIONAL NCT00619554

A Study on the Intraject Instructions for Use

Zogenix Intraject Instructions for Use Pilot Study

Sponsor: Zogenix, Inc.

Conditions Healthy

Updated 7 times since 2017 Last updated: Nov 8, 2022 Started: Jul 31, 2007 Primary completion: Aug 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Healthy and is currently completed. Zogenix, Inc. leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2022 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zogenix, Inc.

Data source: UCB Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.